I-Paclitaxel iyisidakamizwa esinamandla sokulwa nomdlavuza esibe yingxenye ebalulekile yokwelashwa komdlavuza ngenxa yendlela eyingqayizivele kanye nezinzuzo eziningi zokwelapha.Umuthi ekuqaleni wawuhlukanisiwe ne-Pacific yew tree (Taxus brevifolia) ngo-1971, futhi ngemva kweminyaka yocwaningo nokuthuthuka, ususetshenziswe kabanzi emikhakheni eminingi yomdlavuza.Leli phepha lizokwethula izindawo zokusebenza eziyinhloko zepaclitaxel APIkanye neqhaza layo elibalulekile kulezi zindawo.
1. Ukwelashwa komdlavuza wesibeletho:
I-Paclitaxelngokuvamile isetshenziselwa ukwelapha umdlavuza wesibeletho.Ingasetshenziswa njengokwelashwa komugqa wokuqala noma, kanye neminye imithi, njengokwelashwa okungeziwe komdlavuza wesibeletho othuthukile.I-Paclitaxel ivimbela ngempumelelo ukukhula nokusabalala kwamangqamuzana omdlavuza ngokuphazamisa i-mitosis yamaseli wesimila.
2. Ukwelashwa Komdlavuza Webele:
Ezigulini ezinomdlavuza webele, i-paclitaxel ivamise ukusetshenziswa ngokuhlanganiswa nezinye izidakamizwa ezilwa nomdlavuza, ikakhulukazi umdlavuza webele osuthuthukile noma ophindelelayo.Kuyasiza ukunciphisa usayizi wesimila futhi kuthuthukise ukusebenza kahle kokwelashwa.
3. Ukwelashwa komdlavuza wamaphaphu:
Umdlavuza wamaphaphu ongewona omncane (NSCLC) uwuhlobo oluvamile lomdlavuza wamaphaphu, futhi i-paclitaxel isetshenziswa kabanzi njengokwelashwa komugqa wokuqala noma i-adjuvant ye-NSCLC.Kuyasiza ukunciphisa izinga lokukhula kwezimila futhi kuthuthukise amazinga okusinda.
4. Ukwelashwa komdlavuza womlomo wesibeletho:
I-Paclitaxel isetshenziswa ngokuhlanganyela ne-Cisplatin ekwelapheni umdlavuza womlomo wesibeletho, ngokuvamile njengengxenye yokwelapha ngemisebe ye-adjuvant.Lokhu kwelashwa okuhlangene kuthuthukise kakhulu izinga lokusinda kweziguli ezinomdlavuza womlomo wesibeletho.
5. Ukwelashwa komdlavuza wesisu:
I-Paclitaxel kwesinye isikhathi isetshenziswa ekwelapheni umdlavuza wesisu noma wommizo, imvamisa ihlanganiswa neminye imishanguzo elwa nomdlavuza ukunciphisa ukukhula nokusabalala kwesimila.
6. Ukwelashwa Komdlavuza Wendlala Yesinye:
I-Paclitaxel futhi ingasetshenziswa ekwelapheni umdlavuza wendlala yesinye, ikakhulukazi lapho umdlavuza ususabalele kwezinye izitho.Ingakwazi ukulawula ukukhula kwezimila futhi inciphise izimpawu.
7. Ukwelashwa Komdlavuza We-pancreatic:
I-Paclitaxel ivame ukusetshenziswa kanye neminye imithi ukusiza iziguli ukuthi zisinde umdlavuza we-pancreatic.
8. Ukwelashwa kwe-Non-hodgkin lymphoma:
I-Paclitaxeliphinde isetshenziswe ekwelapheni i-non-Hodgkin's lymphoma, ngokuvamile ihlanganiswa neminye imithi yokwelapha ngamakhemikhali ukuze kuncishiswe inqwaba ye-lymphoma.
9. Ukwelashwa kwezimila zobuchopho eziyinhloko noma ze-metastatic:
I-Paclitaxel ngezinye izikhathi isetshenziselwa ukwelapha izimila zobuchopho eziyinhloko noma ze-metastatic, kodwa idinga ukulawulwa kuwo wonke umgoqo wegazi nobuchopho, engakwazi ukuweqa kalula.
Sengiphetha, i-paclitaxel apis inezinhlelo zokusebenza ezibalulekile emikhakheni eminingi yomdlavuza.Ngokuphazamisa ukuhlukaniswa kwamaseli omdlavuza, kuvimbela ngempumelelo ukukhula nokusabalala kwamangqamuzana omdlavuza, kunikeze ithemba namathuba okwelashwa ezigulini.Nokho,paclitaxelUkwelashwa kubuye kuhlotshaniswe nemiphumela ethile engemihle, ngakho-ke uhlelo lokwelapha kufanele lunqunywe ngokuvumelana nesimo esithile sesiguli kanye nezincomo zikadokotela zokwandisa ukusebenza kahle nokunciphisa imiphumela emibi.
Qaphela: Izinzuzo ezingaba khona kanye nezicelo ezivezwe kulesi sihloko zithathwe ezincwadini ezishicilelwe.
I-Yunnan Hande Biotechnology Co., Ltd. ibigxile ekukhiqizeni i-paclitaxel iminyaka engu-26, futhi ingumkhiqizi ozimele we-anti-cancer drug paclitaxel API ekhishwe esitshalweni egunyazwe yi-United States FDA, European EDQM, Australia TGA, China CFDA , India, Japan kanye nezinye izinhlaka zokulawula zikazwelonke.Yunnan Hande paclitaxel, spot supply, factory direct sales, wamukelekile ukubuza, 18187887160 (WhatsApp inombolo efanayo)
Isikhathi sokuthumela: Oct-16-2023